FIELD: medicine.
SUBSTANCE: the present innovation deals with the preparation of antimutagenic activity towards chemical mutagens as betulinic acid previously known as an antimutagen towards ultraviolet and as an antioxidant. The decrease of chromosomal aberrations has been shown in animals towards chemical mutagens of dioxidine and cyclophosphamide due to the action of betulinic acid within wide range of dosages.
EFFECT: higher efficiency.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIMUTAGEN | 2004 |
|
RU2266128C1 |
| METHOD FOR ANTIMUTAGENIC EFFECT ON BODY | 2003 |
|
RU2261704C2 |
| METHOD OF ANTI-MUTAGENIC ACTION ON BODY | 1999 |
|
RU2145869C1 |
| ANTIMUTAGENIC AGENT | 2000 |
|
RU2189232C2 |
| METHOD FOR PREVENTION AND CORRECTION OF CYTOGENETIC DISORDER | 2012 |
|
RU2504392C1 |
| METHOD OF ANTOMUTAGENIC IMPACT ON ORGANISM IN EXPERIMENT | 2010 |
|
RU2440135C1 |
| METHOD OF OCCUPATIONAL SELECTION OF PERSONS FOR WORK ON DESTRUCTION OF CHEMICAL WARFARE AGENTS | 2016 |
|
RU2642603C2 |
| RADIOPROTECTIVE AGENT | 1997 |
|
RU2179020C2 |
| MEDICINAL AGENT ELICITING ANTIMUTAGENIC EFFECT | 2004 |
|
RU2258528C1 |
| ANTIMUTAGENIC AGENT | 2019 |
|
RU2698204C1 |
